Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study

Abstract Objective To investigate the risk of immune-mediated inflammatory diseases (IMIDs) in patients with ankylosing spondylitis (AS). Methods Using 2003–2012 claims data from the Taiwanese National Health Insurance Research Database, we identified 30,911 newly diagnosed AS patients requiring med...

Full description

Bibliographic Details
Main Authors: Hsin-Hua Chen, Wen-Cheng Chao, Yi-Hsing Chen, Tsu-Yi Hsieh, Kuo-Lung Lai, Yi-Ming Chen, Wei-Ting Hung, Ching-Tsai Lin, Chih-Wei Tseng, Ching-Heng Lin
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13075-019-1980-1
id doaj-245a9904991a4ecc9aaf9b453a26c9b9
record_format Article
spelling doaj-245a9904991a4ecc9aaf9b453a26c9b92020-11-25T03:41:18ZengBMCArthritis Research & Therapy1478-63622019-08-012111910.1186/s13075-019-1980-1Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort studyHsin-Hua Chen0Wen-Cheng Chao1Yi-Hsing Chen2Tsu-Yi Hsieh3Kuo-Lung Lai4Yi-Ming Chen5Wei-Ting Hung6Ching-Tsai Lin7Chih-Wei Tseng8Ching-Heng Lin9Department of Medical Research, Taichung Veterans General HospitalDepartment of Medical Research, Taichung Veterans General HospitalDivision of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General HospitalDivision of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General HospitalDivision of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General HospitalDepartment of Medical Research, Taichung Veterans General HospitalDivision of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General HospitalDivision of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General HospitalDivision of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General HospitalDepartment of Medical Research, Taichung Veterans General HospitalAbstract Objective To investigate the risk of immune-mediated inflammatory diseases (IMIDs) in patients with ankylosing spondylitis (AS). Methods Using 2003–2012 claims data from the Taiwanese National Health Insurance Research Database, we identified 30,911 newly diagnosed AS patients requiring medical therapy from 2006 to 2012. In addition, we randomly selected 309,110 non-AS individuals matching (1:10) the AS patients with regard to age, sex and the year of the index date. After excluding subjects with the corresponding prior IMIDs, we calculated the incidence rates (IRs) of various IMIDs in the AS and non-AS cohorts and estimated the hazard ratios (HRs) with 95% confidence intervals after adjusting for age, sex, the Charlson comorbidity index, the frequency of ambulatory visits during the follow-up period and medications. We conducted sensitivity analyses by excluding those who developed IMIDs within 3 months after the index date. Results In the follow-up period, we found that newly diagnosed AS patients had significantly increased risks of acute anterior uveitis, psoriasis, Sjögren’s syndrome, thromboangiitis obliterans, Behcet’s disease and sarcoidosis. However, the risk of Sjögren’s syndrome did not increase in AS patients in the sensitivity analysis. In the same period, this study found no significant differences in the risks of Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis, polymyositis, pemphigus and vitiligo between newly diagnosed AS patients and non-AS individuals. AS patients had a significantly reduced risk of rheumatoid arthritis. Conclusion Newly diagnosed Taiwanese AS patients had increased risks of acute anterior uveitis, psoriasis, thromboangiitis obliterans, Behcet’s disease and sarcoidosis, but a reduced risk of rheumatoid arthritis.http://link.springer.com/article/10.1186/s13075-019-1980-1Ankylosing spondylitisImmune-mediated inflammatory diseaseIncidence
collection DOAJ
language English
format Article
sources DOAJ
author Hsin-Hua Chen
Wen-Cheng Chao
Yi-Hsing Chen
Tsu-Yi Hsieh
Kuo-Lung Lai
Yi-Ming Chen
Wei-Ting Hung
Ching-Tsai Lin
Chih-Wei Tseng
Ching-Heng Lin
spellingShingle Hsin-Hua Chen
Wen-Cheng Chao
Yi-Hsing Chen
Tsu-Yi Hsieh
Kuo-Lung Lai
Yi-Ming Chen
Wei-Ting Hung
Ching-Tsai Lin
Chih-Wei Tseng
Ching-Heng Lin
Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
Arthritis Research & Therapy
Ankylosing spondylitis
Immune-mediated inflammatory disease
Incidence
author_facet Hsin-Hua Chen
Wen-Cheng Chao
Yi-Hsing Chen
Tsu-Yi Hsieh
Kuo-Lung Lai
Yi-Ming Chen
Wei-Ting Hung
Ching-Tsai Lin
Chih-Wei Tseng
Ching-Heng Lin
author_sort Hsin-Hua Chen
title Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
title_short Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
title_full Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
title_fullStr Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
title_full_unstemmed Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
title_sort risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
publisher BMC
series Arthritis Research & Therapy
issn 1478-6362
publishDate 2019-08-01
description Abstract Objective To investigate the risk of immune-mediated inflammatory diseases (IMIDs) in patients with ankylosing spondylitis (AS). Methods Using 2003–2012 claims data from the Taiwanese National Health Insurance Research Database, we identified 30,911 newly diagnosed AS patients requiring medical therapy from 2006 to 2012. In addition, we randomly selected 309,110 non-AS individuals matching (1:10) the AS patients with regard to age, sex and the year of the index date. After excluding subjects with the corresponding prior IMIDs, we calculated the incidence rates (IRs) of various IMIDs in the AS and non-AS cohorts and estimated the hazard ratios (HRs) with 95% confidence intervals after adjusting for age, sex, the Charlson comorbidity index, the frequency of ambulatory visits during the follow-up period and medications. We conducted sensitivity analyses by excluding those who developed IMIDs within 3 months after the index date. Results In the follow-up period, we found that newly diagnosed AS patients had significantly increased risks of acute anterior uveitis, psoriasis, Sjögren’s syndrome, thromboangiitis obliterans, Behcet’s disease and sarcoidosis. However, the risk of Sjögren’s syndrome did not increase in AS patients in the sensitivity analysis. In the same period, this study found no significant differences in the risks of Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis, polymyositis, pemphigus and vitiligo between newly diagnosed AS patients and non-AS individuals. AS patients had a significantly reduced risk of rheumatoid arthritis. Conclusion Newly diagnosed Taiwanese AS patients had increased risks of acute anterior uveitis, psoriasis, thromboangiitis obliterans, Behcet’s disease and sarcoidosis, but a reduced risk of rheumatoid arthritis.
topic Ankylosing spondylitis
Immune-mediated inflammatory disease
Incidence
url http://link.springer.com/article/10.1186/s13075-019-1980-1
work_keys_str_mv AT hsinhuachen riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT wenchengchao riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT yihsingchen riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT tsuyihsieh riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT kuolunglai riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT yimingchen riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT weitinghung riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT chingtsailin riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT chihweitseng riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
AT chinghenglin riskofimmunemediatedinflammatorydiseasesinnewlydiagnosedankylosingspondylitispatientsapopulationbasedmatchedcohortstudy
_version_ 1724530469322620928